Joshua Hyong-Jin Choمشاهده پروفایل
استاد بالینی
- Insomnia
- Depression
- Inflammation
- +۴ مورد دیگر
Joshua Hyong-Jin Cho, MD, PhD, MSc, FAPA, is a Health Sciences Clinical Professor at the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, and Founding Director of the UCLA Insomnia Clinic. He is a board-certified psychiatrist with dual expertise in medicine and epidemiology. Dr. Cho's research focuses on the role of inflammation in depression, fatigue, and sleep disturbance—collectively termed 'sickness behavior.' His work spans psychoneuroimmunology, sleep medicine, and epidemiology, with particular emphasis on how sleep disturbances activate inflammatory pathways and contribute to mood disorders. His clinical activities center on treating insomnia and depression, utilizing both pharmacological and cognitive behavioral approaches. Analysis of Dr. Cho's recent publications reveals a strong focus on the intersection of sleep disorders, inflammation, and aging. His work increasingly incorporates translational approaches, connecting molecular mechanisms with clinical outcomes in older adults. He has made significant contributions to understanding how sleep maintenance issues—not just sleep duration—activate inflammatory pathways, with important sex differences in these relationships. NIH R21 Exploratory/Developmental Research Grant Award NIH K23 Career Development Award UCLA CTSI KL2 Translational Science Award NARSAD Young Investigator Grant UCLA MSTAR Best Research Mentor Award American Psychiatric Association Award Dr. Cho has served as Principal Investigator on multiple NIH-funded studies examining sleep loss as a vulnerability factor for inflammation-induced depressive symptoms, particularly in older women. His mentorship has been recognized with the UCLA MSTAR Best Research Mentor Award. At the UCLA Insomnia Clinic, which he founded, Dr. Cho leads a team focused on evidence-based treatments for sleep disorders, particularly cognitive behavioral therapy for insomnia (CBT-I) and its adjunctive treatments.